Arrowpoint Investment Partners
Latest statistics and disclosures from Arrowpoint Investment Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IGV, KWEB, GOOGL, SMH, EWZ, and represent 46.08% of Arrowpoint Investment Partners's stock portfolio.
- Added to shares of these 10 stocks: IGV (+$19M), KWEB (+$9.2M), GOOGL (+$8.5M), SMH (+$8.4M), EWZ, ASX, BMRN, AXSM, NBIX, PTCT.
- Started 38 new stock positions in MRNA, DXCM, VSTM, NMRA, SMH, ILMN, SMMT, BMRN, EQH, ERAS.
- Reduced shares in these 10 stocks: NVDA (-$83M), JNJ (-$75M), MSFT (-$70M), C (-$54M), HD (-$54M), QCOM (-$54M), PLTR (-$50M), RSP (-$32M), AMZN (-$20M), AAPL (-$20M).
- Sold out of its positions in ASTS, ABBV, ABVX, ACAD, AEG, AMZN, AMKR, APH, APLS, AAPL.
- Arrowpoint Investment Partners was a net seller of stock by $-580M.
- Arrowpoint Investment Partners has $113M in assets under management (AUM), dropping by -83.42%.
- Central Index Key (CIK): 0002032331
Tip: Access up to 7 years of quarterly data
Positions held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Arrowpoint Investment Partners
Arrowpoint Investment Partners holds 81 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Expanded Tech Call Option (IGV) | 16.4 | $19M | NEW | 231k | 80.05 |
|
| Kraneshares Trust Csi Chi Internet (KWEB) | 10.1 | $11M | +431% | 400k | 28.43 |
|
| Alphabet Cap Stk Cl A (GOOGL) | 8.0 | $9.0M | +2123% | 31k | 287.56 |
|
| Vaneck Etf Trust Semiconductr Etf Put Option (SMH) | 7.5 | $8.4M | NEW | 22k | 383.27 |
|
| Ishares Msci Brazil Etf Call Option (EWZ) | 4.1 | $4.6M | NEW | 120k | 38.39 |
|
| Ase Technology Hldg Sponsored Ads (ASX) | 3.5 | $3.9M | NEW | 180k | 21.68 |
|
| Ionis Pharmaceuticals (IONS) | 2.6 | $2.9M | +55% | 39k | 75.09 |
|
| Neurocrine Biosciences (NBIX) | 2.5 | $2.8M | +512% | 22k | 131.74 |
|
| Axsome Therapeutics (AXSM) | 2.5 | $2.8M | +677% | 16k | 169.02 |
|
| BioMarin Pharmaceutical (BMRN) | 2.4 | $2.8M | NEW | 49k | 56.49 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.4 | $2.7M | +294% | 12k | 228.73 |
|
| Ptc Therapeutics I (PTCT) | 2.4 | $2.7M | +329% | 40k | 68.13 |
|
| Pfizer (PFE) | 1.8 | $2.0M | +64% | 71k | 28.08 |
|
| Regeneron Pharmaceuticals (REGN) | 1.7 | $1.9M | +62% | 2.5k | 772.64 |
|
| Johnson & Johnson (JNJ) | 1.7 | $1.9M | -97% | 7.9k | 244.44 |
|
| Amgen (AMGN) | 1.5 | $1.7M | -17% | 4.9k | 351.85 |
|
| Gilead Sciences (GILD) | 1.5 | $1.7M | -38% | 12k | 139.37 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.4 | $1.5M | 3.4k | 446.54 |
|
|
| Microchip Technology Note 0.750% 6/0 (Principal) | 1.3 | $1.5M | NEW | 1.5M | 0.99 |
|
| UnitedHealth (UNH) | 1.3 | $1.4M | NEW | 5.2k | 270.59 |
|
| Praxis Precision Medicines I Com New (PRAX) | 1.1 | $1.2M | +85% | 3.9k | 322.19 |
|
| Insmed Com Par $.01 (INSM) | 1.0 | $1.1M | -39% | 7.0k | 163.52 |
|
| Protagonist Therapeutics (PTGX) | 0.9 | $984k | NEW | 9.3k | 105.40 |
|
| Belite Bio Sponsored Ads (BLTE) | 0.9 | $957k | +96% | 6.0k | 159.44 |
|
| Ishares Msci Taiwan Etf (EWT) | 0.8 | $887k | NEW | 13k | 70.92 |
|
| Moderna (MRNA) | 0.8 | $869k | NEW | 17k | 50.80 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 0.8 | $867k | NEW | 3.5k | 247.82 |
|
| Biogen Idec (BIIB) | 0.8 | $863k | +64% | 4.7k | 183.33 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.7 | $777k | -83% | 26k | 30.12 |
|
| Revolution Medicines (RVMD) | 0.7 | $775k | +149% | 8.0k | 97.25 |
|
| Select Sector Spdr Tr State Street Uti (XLU) | 0.7 | $753k | -68% | 16k | 45.89 |
|
| Octave Specialty Group Com New (OSG) | 0.6 | $647k | -31% | 139k | 4.65 |
|
| Twist Bioscience Corp (TWST) | 0.6 | $640k | +34% | 14k | 47.52 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $624k | +221% | 1.2k | 523.47 |
|
| Ishares Tr 20 Yr Tr Bd Etf (TLT) | 0.5 | $616k | NEW | 7.1k | 86.69 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.5 | $612k | NEW | 6.9k | 88.88 |
|
| Natera (NTRA) | 0.5 | $594k | NEW | 3.0k | 199.99 |
|
| Axogen (AXGN) | 0.5 | $539k | -15% | 16k | 33.13 |
|
| Select Sector Spdr Tr State Street Ind (XLI) | 0.5 | $534k | +17% | 3.3k | 161.73 |
|
| Cogent Biosciences (COGT) | 0.5 | $531k | +87% | 14k | 38.49 |
|
| Select Sector Spdr Tr State Street Ene (XLE) | 0.5 | $521k | +372% | 8.5k | 61.26 |
|
| Select Sector Spdr Tr State Street Con (XLP) | 0.5 | $517k | NEW | 6.3k | 81.98 |
|
| Cytokinetics Com New (CYTK) | 0.4 | $487k | +64% | 7.4k | 65.91 |
|
| Genmab A/s Sponsored Ads (GMAB) | 0.4 | $430k | -62% | 16k | 26.83 |
|
| Bridgebio Pharma (BBIO) | 0.4 | $430k | +97% | 5.8k | 74.26 |
|
| Tango Therapeutics (TNGX) | 0.4 | $428k | NEW | 21k | 20.92 |
|
| Cooper Cos (COO) | 0.4 | $422k | -43% | 5.9k | 71.50 |
|
| Eli Lilly & Co. (LLY) | 0.4 | $407k | -95% | 442.00 | 919.77 |
|
| Erasca (ERAS) | 0.4 | $402k | NEW | 25k | 16.18 |
|
| Lumentum Hldgs (LITE) | 0.4 | $395k | -95% | 562.00 | 702.76 |
|
| Illumina (ILMN) | 0.3 | $373k | NEW | 3.0k | 123.26 |
|
| Bioage Labs (BIOA) | 0.3 | $364k | NEW | 21k | 17.49 |
|
| Apogee Therapeutics (APGE) | 0.3 | $337k | -36% | 4.0k | 84.17 |
|
| Immunitybio (IBRX) | 0.3 | $315k | NEW | 41k | 7.67 |
|
| United Therapeutics Corporation (UTHR) | 0.3 | $313k | NEW | 527.00 | 592.98 |
|
| Dyne Therapeutics (DYN) | 0.3 | $312k | +19% | 17k | 18.13 |
|
| Spyre Therapeutics Com New (SYRE) | 0.3 | $310k | -55% | 6.1k | 50.44 |
|
| Tyra Biosciences (TYRA) | 0.3 | $309k | NEW | 8.1k | 38.30 |
|
| Select Sector Spdr Tr State Street Fin (XLF) | 0.3 | $306k | -73% | 6.2k | 49.37 |
|
| State Str Spdr S&p 500 Etf T Tr Unit (SPY) | 0.2 | $273k | NEW | 420.00 | 650.34 |
|
| Alumis (ALMS) | 0.2 | $265k | NEW | 12k | 22.03 |
|
| Oruka Therapeutics (ORKA) | 0.2 | $253k | NEW | 5.1k | 49.05 |
|
| Equitable Holdings (EQH) | 0.2 | $252k | NEW | 6.8k | 37.11 |
|
| Franklin Templeton Etf Tr Ftse Taiwan (FLTW) | 0.2 | $252k | NEW | 3.7k | 68.11 |
|
| Summit Therapeutics (SMMT) | 0.2 | $230k | NEW | 12k | 18.96 |
|
| Envista Hldgs Corp (NVST) | 0.2 | $228k | -38% | 9.0k | 25.37 |
|
| Cg Oncology (CGON) | 0.2 | $228k | NEW | 3.4k | 67.68 |
|
| Dex (DXCM) | 0.2 | $228k | NEW | 3.6k | 62.80 |
|
| Nektar Therapeutics Com New (NKTR) | 0.2 | $204k | -42% | 2.8k | 71.95 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $202k | NEW | 4.2k | 48.20 |
|
| Verastem Com New (VSTM) | 0.2 | $192k | NEW | 36k | 5.30 |
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 0.2 | $184k | -67% | 2.0k | 91.77 |
|
| Eliem Therapeutics (CLYM) | 0.1 | $168k | NEW | 25k | 6.85 |
|
| United States Antimony (UAMY) | 0.1 | $100k | NEW | 11k | 8.73 |
|
| Alphabet Cap Stk Cl C (GOOG) | 0.1 | $86k | +50% | 300.00 | 286.86 |
|
| Iovance Biotherapeutics (IOVA) | 0.1 | $69k | NEW | 20k | 3.51 |
|
| Neumora Therapeutics (NMRA) | 0.0 | $31k | NEW | 16k | 1.95 |
|
| Brandywine Rlty Tr Sh Ben Int New (BDN) | 0.0 | $29k | NEW | 11k | 2.71 |
|
| Select Sector Spdr Tr State Street Tec (XLK) | 0.0 | $27k | -97% | 200.00 | 132.90 |
|
| Plug Pwr Com New (PLUG) | 0.0 | $25k | NEW | 11k | 2.26 |
|
| Ishares Tr Msci India Etf (INDA) | 0.0 | $23k | 500.00 | 46.84 |
|
Past Filings by Arrowpoint Investment Partners
SEC 13F filings are viewable for Arrowpoint Investment Partners going back to 2024
- Arrowpoint Investment Partners 2026 Q1 filed May 14, 2026
- Arrowpoint Investment Partners 2025 Q4 filed Feb. 11, 2026
- Arrowpoint Investment Partners 2025 Q3 filed Nov. 14, 2025
- Arrowpoint Investment Partners 2025 Q2 filed Aug. 13, 2025
- Arrowpoint Investment Partners 2025 Q1 filed May 13, 2025
- Arrowpoint Investment Partners 2024 Q4 filed Feb. 18, 2025